Loss-of-function genetics in mammalian cells: the p53 tumor suppressor model.
暂无分享,去创建一个
G. Hannon | D. Beach | J. Hudson | A. Carnero
[1] B. Foster,et al. Pharmacological rescue of mutant p53 conformation and function. , 1999, Science.
[2] S. Syrjänen,et al. New concepts on the role of human papillomavirus in cell cycle regulation. , 1999, Annals of medicine.
[3] G. Hannon,et al. MaRX: An Approach to Genetics in Mammalian Cells , 1999, Science.
[4] R. Brown,et al. p53-oriented cancer therapies: current progress. , 1999, Annals of oncology : official journal of the European Society for Medical Oncology.
[5] D. Wynford‐Thomas. Cellular senescence and cancer , 1999, The Journal of pathology.
[6] D. Lane,et al. The p53 tumour suppressor gene , 1998, The British journal of surgery.
[7] S. Lowe,et al. Premature senescence involving p53 and p16 is activated in response to constitutive MEK/MAPK mitogenic signaling. , 1998, Genes & development.
[8] G. Mills,et al. Reexpression of the retinoblastoma protein in tumor cells induces senescence and telomerase inhibition , 1997, Oncogene.
[9] Stephen N. Jones,et al. Regulation of p53 stability by Mdm2 , 1997, Nature.
[10] M. Oren,et al. Mdm2 promotes the rapid degradation of p53 , 1997, Nature.
[11] S. Lowe,et al. Oncogenic ras Provokes Premature Cell Senescence Associated with Accumulation of p53 and p16INK4a , 1997, Cell.
[12] I. Roninson,et al. Identification of p53 genetic suppressor elements which confer resistance to cisplatin , 1997, Oncogene.
[13] J. Blaydes,et al. Evidence that transcriptional activation by p53 plays a direct role in the induction of cellular senescence. , 1996, Oncogene.
[14] D. Wazer,et al. Mutant p53-induced immortalization of primary human mammary epithelial cells. , 1996, Cancer research.
[15] C. Prives,et al. p53: puzzle and paradigm. , 1996, Genes & development.
[16] L. Gollahon,et al. Immortalization of human mammary epithelial cells transfected with mutant p53 (273his). , 1996, Oncogene.
[17] E. Androphy,et al. Mutational analysis of human papillomavirus type 16 E6 demonstrates that p53 degradation is necessary for immortalization of mammary epithelial cells , 1996, Journal of virology.
[18] I. Mazo,et al. Genetic suppressor elements: new tools for molecular oncology--thirteenth Cornelius P. Rhoads Memorial Award Lecture. , 1995, Cancer research.
[19] R. Reddel,et al. Alterations in p53 and p16INK4 expression and telomere length during spontaneous immortalization of Li-Fraumeni syndrome fibroblasts , 1995, Molecular and cellular biology.
[20] G. Stein,et al. Origins of G1 arrest in senescent human fibroblasts , 1995, BioEssays : news and reviews in molecular, cellular and developmental biology.
[21] D. Lane. p53 and human cancers. , 1994, British medical bulletin.
[22] J. Trent,et al. WAF1, a potential mediator of p53 tumor suppression , 1993, Cell.
[23] J. Barrett,et al. Genetic and molecular basis for cellular senescence. , 1993, Advances in experimental medicine and biology.
[24] D. Denhardt,et al. Mechanism of Action of Antisense RNA. Sometime Inhibition of Transcription, Processing, Transport, or Translation a , 1992, Annals of the New York Academy of Sciences.
[25] Bert Vogelstein,et al. p53 function and dysfunction , 1992, Cell.
[26] C. Finlay,et al. What the papers say: p53 Loss of Function: Implications for the Processes of Immortalization and Tumorigenesis , 1992 .
[27] J. Shay,et al. The two-stage mechanism controlling cellular senescence and immortalization , 1992, Experimental Gerontology.
[28] I. Roninson,et al. Isolation of dominant negative mutants and inhibitory antisense RNA sequences by expression selection of random DNA fragments. , 1992, Nucleic Acids Research.
[29] A. Rhodes,et al. Inhibition of human immunodeficiency virus replication in cell culture by endogenously synthesized antisense RNA. , 1990, The Journal of general virology.
[30] P. Palese,et al. Expression of antisense RNA fails to inhibit influenza virus replication , 1989, Virus Research.
[31] J. Mol,et al. Antisense genes in plants: an overview. , 1988, Gene.
[32] G. Stark,et al. Excess antisense RNA from infectious recombinant SV40 fails to inhibit expression of a transfected, interferon-inducible gene. , 1988, European journal of biochemistry.
[33] B. Wold,et al. Stable reduction of thymidine kinase activity in cells expressing high levels of anti-sense RNA , 1985, Cell.
[34] H. Weintraub,et al. Constitutive and conditional suppression of exogenous and endogenous genes by anti-sense RNA. , 1985, Science.
[35] K. Hagino-Yamagishi,et al. [Oncogene]. , 2019, Gan to kagaku ryoho. Cancer & chemotherapy.